Motion Sickness Drugs Market

Global Motion Sickness Drugs Market Size, Share & Trends Analysis Report, By Treatment Type (Anticholinergics, Antihistamines, and others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies and Others), Forecast (2021-2027)

Published: Jan 2022 | Report Code: OMR2025435 | Category : Pharmaceuticals | Delivery Format: /

The global motion sickness drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Motion sickness is a common disorder characterized by a set of symptoms such as dizziness, nausea, and fatigue experienced by a person while travelling due to differences in impulses in the eyes, other body tissues, and sensory receptors. Motion sickness is most commonly observed among children and geriatrics. It is experienced by about 50% to 70% of travellers and even while playing virtual reality (VR) games. The pivotal factors that are driving the market growth include a rise in the number of travellers across the globe and increased incidences of CVD in the geriatric population which majorly cause motion sickness.

For instance, as per the United Nations World Tourism Organization (UNWTO), international tourist arrivals increased by 5.4% in 2018 compared to 2017, and this tendency is expected to continue during the forecast period which demands higher requirements for motion sickness treatment globally. Also, ongoing research activities in motion sickness drug development and delivery systems are likely to increase the availability of OTC drugs for motion sickness treatment. Furthermore, some key players operating in the market include Prestige Consumer Healthcare Inc., WellSpring Pharmaceutical Corp., and CVS Health Corp., among others.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape: Prestige Consumer Healthcare Inc., WellSpring Pharmaceutical Corp., and CVS Health Corp., among others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Motion Sickness Drugs Market by Segment

By Treatment Type 

Anticholinergics

Antihistamines

Others

By Distribution Channel 

Retail Pharmacies

Online Pharmacies 

Others

Global Motion Sickness Drugs Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World